Thermo Fisher is also manufacturing diabetes medications for our pharmaceutical customers, including oral solid dose to sterile injectable therapies – from development to commercialization.
According to the World Health Organization, diabetes was the direct cause of 1.5 million deaths in 2019, and of those, 48% occurred before the age of 70 years. Today and every day, we are proud to support and enable efforts to diagnose and treat diabetes and ultimately improve outcomes for patients around the world.